ABSTRACT BACKGROUND Despite great advances in assisted reproductive technology,
poor ovarian response (POR) is still considered as one of the most challenging tasks in …

Secreted by the anterior pituitary gland, growth hormone (GH) is a peptide that plays a
critical role in regulating cell growth, development, and metabolism in multiple targeted …

Objective: The development of these guidelines is sponsored by the American Association
of Clinical Endocrinologists (AACE) Board of Directors and American College of …

It is well-known that poor ovarian reserve is a cause of infertility, poor response to
gonadotrophin stimulation and poor success rate after in vitro fertilization (IVF) cycles. Some …

Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …

Objective To evaluate the effectiveness of growth hormone (GH) supplementation in
improving the in vitro fertilization (IVF) outcomes of poor responders. Design Systematic …

Controlled ovarian stimulation with subsequent multi-follicular development continues to be
a keystone in ART. Evidence supports an individualized approach to ovarian stimulation …

Purpose To investigate whether growth hormone (GH) could improve pregnancy rates of
patients with thin endometrium by clinical study and laboratory experiments. Materials and …

Background Many studies have demonstrated the benefits of the addition of growth hormone
(GH) to the controlled ovarian stimulation protocol in vitro fertilization (IVF) cycles in poor …

The prevalence of poor response to gonadotropin stimulation is approximately 9–24% in
women undergoing in vitro fertilization. Interestingly, due to containing a variety of growth …